Evidence map›Paper›PMID 34966948›Full record

ArticleCellular and molecular life sciences : CMLS2021

Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E, protects human neurons against oxidative/neuroexcitotoxic stress via β-arrestin/ERK signaling.

Vinay Kumar Sharma, Xuyu Yang, Soo-Kyung Kim, Amirhossein Mafi, Daniel Saiz-Sanchez, Patricia Villanueva-Anguita, Lan Xiao, Asuka Inoue, William A Goddard, Y Peng Loh

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Predicted molecules followed by experimental validation for protecting human neurons from oxidative stress-induced cytotoxicity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Alleviating CB2-Dependent ER Stress and Mitochondrial Dysfunction Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  11. Article
  12. Characterization of serotonin-5-HTR1E signaling pathways and its role in cell survival.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Vinay Kumar SharmaSection on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 49, Convent Drive, Bldg 49, Rm 6A-10, Bethesda, MD, 20892, USA.
Xuyu YangSection on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 49, Convent Drive, Bldg 49, Rm 6A-10, Bethesda, MD, 20892, USA.
Soo-Kyung Kim *Materials and Process Simulation Center, California Institute of Technology, Pasedena, CA, 91125, USA.
Amirhossein Mafi *Materials and Process Simulation Center, California Institute of Technology, Pasedena, CA, 91125, USA.
Daniel Saiz-Sanchez *Neuroplasticity and Neurodegeneration Laboratory, Medical School, Regional Center for Biomedical Research, University of Castilla-La Mancha, 13071, Ciudad Real, Spain.
Patricia Villanueva-AnguitaNeuroplasticity and Neurodegeneration Laboratory, Medical School, Regional Center for Biomedical Research, University of Castilla-La Mancha, 13071, Ciudad Real, Spain.
Lan XiaoSection on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 49, Convent Drive, Bldg 49, Rm 6A-10, Bethesda, MD, 20892, USA.
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, 980-8578, Japan.
William A GoddardMaterials and Process Simulation Center, California Institute of Technology, Pasedena, CA, 91125, USA. wag@caltech.edu.
Y Peng LohSection on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 49, Convent Drive, Bldg 49, Rm 6A-10, Bethesda, MD, 20892, USA. lohp@mail.nih.gov.ORCID http://orcid.org/0000-0002-5404-723X
National Institutes of Health · USCalifornia Institute of Technology · USUniversity of Castilla-La Mancha · ESTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protecting neurons from death during oxidative and neuroexcitotoxic stress is key for preventing cognitive dysfunction. We uncovered a novel neuroprotective mechanism involving interaction between neurotrophic factor-α1 (NF-α1/carboxypeptidase E, CPE) and human 5-HTR1E, a G protein-coupled serotonin receptor with no previously known neurological function. Co-immunoprecipitation and pull-down assays confirmed interaction between NFα1/CPE and 5-HTR1E and

Indexed as

MAP Kinase Signaling SystemOxidative StressAnimalsbeta-ArrestinsCarboxypeptidase HCell SurvivalCyclic AMPCyclic AMP Response Element-Binding ProteinDown-RegulationHEK293 CellsHippocampusHumansMiceMolecular Docking SimulationMolecular Dynamics SimulationNerve Growth Factorsbeta-ArrestinsCarboxypeptidase HCyclic AMPCyclic AMP Response Element-Binding ProteinNerve Growth FactorsNeuroprotective AgentsNeurotoxinsReceptors, SerotoninCytotoxicityGPCRNeuroprotectionβ-arrestin

Identifiers

PMID34966948
PMCPMC8732845
OpenAlexW4200108255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.